drugs

More Crazy Tax Deductions: What Worked, What Didn't

From hip replacements to pole dancing classes, here are some of the most outlandish deductions taxpayers have ever attempted to claim. You won't believe what these people tried that their accountants said wouldn't fly -- and you really won't believe what did (literally).

CVS Grows Insurance-Claims Processing Biz

CVS Caremark is best known for its drugstore busines. But it's also finding its way into the business of managing prescription-drug insurance claims. After taking some heat in the last few quarters, it is starting to see revenue from some big contracts in this segment.

Is Walgreen Going Too Far With Its Higher Dividend?

Walgreen, the leading U.S. pharmacy chain, recently increased its quarterly dividend by 28.6%, the largest increase in the company's 110-year history, from 17.5 cents a share to 22.5 cents a share. But is it giving away cash it's really going to need for its expansion plans?

How Safe Are the Drugs in Your Medicine Cabinet?

Do you want your new prescription drugs to be made under last century's oversight? Like it or not, that's likely what you're getting -- or worse -- because increasingly, Americans' medicines are made overseas in place where the oversight isn't up to U.S. standards.

How Small Stores Will Impact Values of CVS, Walgreens

CVS Caremark and Walgreen are the leading pharmacy chains in the U.S. While both have been aggressively expanding their retail footprints, there has been a gradual decrease in the average size of the newly opened stores. Here's why they're going small, and what it means for their profits.

America's Priciest Rehab Palaces

Keeping Up With the Joneses: Priciest Rehab PalacesThe rich, powerful and addicted are often willing to pay big bucks to get clean and sober -- but just how much? DailyFinance checked out three of the priciest dry-out retreats in the world. One month's bill at any of the following would be enough to scare many of us straight.

Rehab's Real Tab: The Money Side of Treating Addiction

Singers Whitney Houston and Amy Winehouse both checked back into drug rehab in May. The rich and famous, of course, have the means to bounce in and out of pricey addiction-treatment centers, but what's the real cost of rehab for regular folks trying clean up their lives?

The Five Best-Performing Biotech Stocks of 2011 -- So Far

Pharmaceuticals are facing big patent cliff problems this year, but several biotechnology stocks have been doing quite well: Their biologic drugs command high prices, tend become blockbusters, and -- perhaps most important -- are in far less danger from generic competition. Here are the big winners so far.

Drug-Related Emergency Room Visits Are on the Rise

Roughly 700,000 Americans were taken to the hospital in 2007 after ingesting drugs -- both legal and illegal -- costing $1.4 billion per year in emergency department charges alone, according to a new study.

Top-Selling Drugs About to Lose Patent Protection

The pharmaceutical industry is about to fall off a cliff -- a patent cliff. Over the next few years, some of the world's most popular and lucrative medicines will go off patent, and generic competition will siphon an estimated quarter of a trillion dollars from companies' bottom lines. Here's a rundown:

Why Samsung Electronics Should Say No to Drugs

Samsung Electronics is known for its smartphones, TVs and memory chips. Now it wants to tackle biopharmaceuticals, on Friday announcing a new joint venture to produce drugs to treat cancer and arthritis.

Big Pharma Looks Beyond Drugs to Smartphone Apps

Pharmaceutical companies looking for fresh sources of profit are increasingly investing in a range of health care innovations that aren't drugs at all, from smartphone apps and educational websites to social media platforms and wireless devices, reports Ernst & Young.